These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21191018)

  • 1. JNK1 is required for lentivirus entry and gene transfer.
    Lee MH; Padmashali R; Andreadis ST
    J Virol; 2011 Mar; 85(6):2657-65. PubMed ID: 21191018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
    Cubero FJ; Zoubek ME; Hu W; Peng J; Zhao G; Nevzorova YA; Al Masaoudi M; Bechmann LP; Boekschoten MV; Muller M; Preisinger C; Gassler N; Canbay AE; Luedde T; Davis RJ; Liedtke C; Trautwein C
    Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherens junction formation inhibits lentivirus entry and gene transfer.
    Padmashali R; You H; Karnik N; Lei P; Andreadis ST
    PLoS One; 2013; 8(11):e79265. PubMed ID: 24236116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun N-terminal kinase 1 (JNK1) is required for coordination of netrin signaling in axon guidance.
    Qu C; Li W; Shao Q; Dwyer T; Huang H; Yang T; Liu G
    J Biol Chem; 2013 Jan; 288(3):1883-95. PubMed ID: 23223444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
    Leventaki V; Drakos E; Medeiros LJ; Lim MS; Elenitoba-Johnson KS; Claret FX; Rassidakis GZ
    Blood; 2007 Sep; 110(5):1621-30. PubMed ID: 17416736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
    Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
    Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
    Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
    Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
    McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
    Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2.
    Takatori A; Geh E; Chen L; Zhang L; Meller J; Xia Y
    Development; 2008 Jan; 135(1):23-32. PubMed ID: 18032450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform.
    Pawate S; Bhat NR
    Antioxid Redox Signal; 2006; 8(5-6):903-9. PubMed ID: 16771680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun N-terminal kinase activity is required for efficient respiratory syncytial virus production.
    Caly L; Li HM; Bogoyevitch MA; Jans DA
    Biochem Biophys Res Commun; 2017 Jan; 483(1):64-68. PubMed ID: 28062184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
    Katagiri C; Negishi K; Hibino T
    J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
    Choi HS; Bode AM; Shim JH; Lee SY; Dong Z
    Mol Cell Biol; 2009 Apr; 29(8):2168-80. PubMed ID: 19204086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis.
    Alexaki VI; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2008 Aug; 21(4):429-38. PubMed ID: 18541008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D; Donin N; Fishelson Z
    Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
    Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
    Oleinik NV; Krupenko NI; Krupenko SA
    Oncogene; 2007 Nov; 26(51):7222-30. PubMed ID: 17525747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
    Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK and p38 mitogen-activated protein kinase pathways contribute to porcine epidemic diarrhea virus infection.
    Lee C; Kim Y; Jeon JH
    Virus Res; 2016 Aug; 222():1-12. PubMed ID: 27215486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.